Impact Biomedical Relocates HQ, Updates Contact Info
Ticker: IBO · Form: 8-K · Filed: Oct 8, 2024 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Oct 8, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $200,000, $250,000, $150,000, $100,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-actions, filing-update
TL;DR
IMPACT BIOMEDICAL INC. MOVED HQ TO HOUSTON, TX. NEW PHONE: (585) 325-3610.
AI Summary
Impact Biomedical Inc. announced on October 3, 2024, a change in its principal executive offices to 1400 Broadfield Blvd., Suite 130, Houston, TX 77084. The company also updated its telephone number to (585) 325-3610. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
A change in principal executive offices and contact information can signal operational shifts or growth for a company.
Risk Assessment
Risk Level: low — This filing primarily concerns administrative changes like office relocation and contact information updates, which typically carry low risk.
Key Players & Entities
- Impact Biomedical Inc. (company) — Registrant
- 1400 Broadfield Blvd., Suite 130, Houston, TX 77084 (location) — New Principal Executive Offices
- (585) 325-3610 (phone_number) — Registrant's telephone number
- October 3, 2024 (date) — Date of earliest event reported
FAQ
What is the new address for Impact Biomedical Inc.'s principal executive offices?
The new address for Impact Biomedical Inc.'s principal executive offices is 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
What is the updated telephone number for Impact Biomedical Inc.?
The updated telephone number for Impact Biomedical Inc. is (585) 325-3610.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is October 3, 2024.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the state of incorporation for Impact Biomedical Inc.?
Impact Biomedical Inc. is incorporated in Nevada.
Filing Stats: 849 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2024-10-08 17:07:14
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share N/A N/A Indic
- $200,000 — al base salary (the " Base Salary ") of $200,000 for the first year of the Employment Te
- $250,000 — the first year of the Employment Term, $250,000 for the second year of the Employment T
- $150,000 — he " Mandatory Bonus ") as follows: (i) $150,000 for the first year of the Employment Te
- $100,000 — first year of the Employment Term; (ii) $100,000 for the second year of the Employment T
- $3.00 — y's common stock at a purchase price of $3.00 per share (which is equal to the fair m
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex10-1.htm (EX-10.1) — 14KB
- ex10-1_001.jpg (GRAPHIC) — 498KB
- ex10-1_002.jpg (GRAPHIC) — 562KB
- ex10-1_003.jpg (GRAPHIC) — 619KB
- ex10-1_004.jpg (GRAPHIC) — 508KB
- ex10-1_005.jpg (GRAPHIC) — 583KB
- ex10-1_006.jpg (GRAPHIC) — 463KB
- ex10-1_007.jpg (GRAPHIC) — 514KB
- ex10-1_008.jpg (GRAPHIC) — 598KB
- ex10-1_009.jpg (GRAPHIC) — 586KB
- ex10-1_010.jpg (GRAPHIC) — 616KB
- ex10-1_011.jpg (GRAPHIC) — 609KB
- ex10-1_012.jpg (GRAPHIC) — 595KB
- ex10-1_013.jpg (GRAPHIC) — 603KB
- ex10-1_014.jpg (GRAPHIC) — 184KB
- 0001493152-24-040465.txt ( ) — 10610KB
- ibo-20241003.xsd (EX-101.SCH) — 3KB
- ibo-20241003_lab.xml (EX-101.LAB) — 33KB
- ibo-20241003_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. IMPACT BIOMEDICAL INC. Date: October 8, 2024 By: /s/ Frank D. Heuszel Name: Frank D. Heuszel Title: Chief Executive Officer